Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00711061 · ClinicalTrials.gov registry record
Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy
A clinical trial of Growth Hormone Deficiency, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- 24
- Enrollment target
- 1
- Study location
NCT00711061: Completed study of Growth Hormone Deficiency, sponsored by Children's Mercy Hospital Kansas City.
NCT00711061 is a study of Growth Hormone Deficiency that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 24 participants, below the 386-participant average among 16 other Growth Hormone Deficiency trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00711061, a study of Growth Hormone Deficiency, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the cardiovascular risks of growth hormone deficient young adult males who have completed growth hormone therapy to healthy young adult males.
Conditions Studied
Study Locations (1)
Missouri
- Childrens Mercy Hospitals and Clinics - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-06 |
| Est. Completion | 2009-02 |
What the finished NCT00711061 record still lists
NCT00711061 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 386-participant average among 16 other Growth Hormone Deficiency trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Growth Hormone Deficiency appearing as the primary indexed condition, and to 0 interventions.
NCT00711061 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT00711061 about?
NCT00711061 is a clinical study titled "Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy". The purpose of this study is to compare the cardiovascular risks of growth hormone deficient young adult males who have completed growth hormone therapy to healthy young adult males.
What is the current status of trial NCT00711061?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2008-06. Estimated completion is 2009-02.
What conditions does trial NCT00711061 study?
This clinical trial studies the following conditions: Growth Hormone Deficiency.
Who is sponsoring clinical trial NCT00711061?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00711061 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Growth Hormone Deficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00711061's enrollment target sits among peer trials
24 12th of 16 higher than 5 of 16 other Growth Hormone Deficiency trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Growth Hormone Deficiency trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
RECRUITING
-
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
RECRUITING
-
Effects of GH and Lirglutide on AgRP
RECRUITING · Phase 4
-
Chromosome 18 Clinical Research Center
RECRUITING
-
Growth Hormone Replacement Therapy for Retried Professional Football Players
RECRUITING · Phase 2
-
Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213)
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia